FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034577350> ?p ?o ?g. }

• W2034577350 endingPage "1329" @default.
• W2034577350 startingPage "1324" @default.
• W2034577350 abstract "OBJECTIVE—Ragaglitazar is a novel insulin sensitizer with dual peroxisome proliferator-activated receptor (PPAR)-γ and PPAR-α stimulating activities that improve plasma glucose and lipid profiles. The aim of the present dose-ranging study was to assess the efficacy and safety of ragaglitazar in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS—This study included 177 hypertriglyceridemic type 2 diabetic subjects who participated in a 12-week, double-blind, parallel, randomized, placebo-controlled dose-ranging study (open pioglitazone arm). Subjects received ragaglitazar (0.1, 1, 4, or 10 mg), placebo, or pioglitazone (45 mg). Efficacy parameters included fasting plasma levels of triglycerides and glucose (FPG) along with other lipid levels, A1C, and insulin. RESULTS—Ragaglitazar in doses of 1, 4, and 10 mg resulted in a significant decrease from baseline as compared with placebo in FPG (−48, −74, −77 mg/dl) and triglycerides (−40, −62, −51%), free fatty acids (−36, −54, −62%), apolipoprotein B (−13, −29, −25%), LDL cholesterol (−14 and −19% for 4- and 10-mg groups), and total cholesterol (−16 and −15% for 4 and 10 mg) and a significant increase in HDL cholesterol (20 and 31% for 1- and 4-mg groups, respectively). Changes in triglycerides and FPG for pioglitazone treatment were similar to 1 mg ragaglitazar. Mean A1C values of the 1-, 4-, and 10-mg ragaglitazar and pioglitazone groups were significantly reduced compared with placebo (−0.5, −1.3, −1.1, and −0.3%, respectively). Common adverse events were edema, weight increase, leukopenia, and anemia. CONCLUSIONS—Ragaglitazar provided glycemic control that was comparable with that of pioglitazone and, compared with placebo, provided significant improvement in the lipid profile." @default.
• W2034577350 created "2016-06-24" @default.
• W2034577350 creator A5013650225 @default.
• W2034577350 creator A5023259092 @default.
• W2034577350 creator A5039965133 @default.
• W2034577350 creator A5053691497 @default.
• W2034577350 creator A5054359089 @default.
• W2034577350 creator A5074778721 @default.
• W2034577350 creator A5089768127 @default.
• W2034577350 date "2004-06-01" @default.
• W2034577350 modified "2023-09-23" @default.
• W2034577350 title "Ragaglitazar Improves Glycemic Control and Lipid Profile in Type 2 Diabetic Subjects" @default.
• W2034577350 cites W1647126819 @default.
• W2034577350 cites W1672804368 @default.
• W2034577350 cites W1973014862 @default.
• W2034577350 cites W2015279471 @default.
• W2034577350 cites W2018715171 @default.
• W2034577350 cites W2020984463 @default.
• W2034577350 cites W2031032207 @default.
• W2034577350 cites W2050695519 @default.
• W2034577350 cites W2060752803 @default.
• W2034577350 cites W2064560407 @default.
• W2034577350 cites W2092621119 @default.
• W2034577350 cites W2095916401 @default.
• W2034577350 cites W2113317508 @default.
• W2034577350 cites W2115728877 @default.
• W2034577350 cites W2123946565 @default.
• W2034577350 cites W2146877877 @default.
• W2034577350 cites W2337454357 @default.
• W2034577350 cites W36311596 @default.
• W2034577350 cites W4214772579 @default.
• W2034577350 cites W4238251256 @default.
• W2034577350 cites W4241871118 @default.
• W2034577350 cites W91098912 @default.
• W2034577350 doi "https://doi.org/10.2337/diacare.27.6.1324" @default.
• W2034577350 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15161783" @default.
• W2034577350 hasPublicationYear "2004" @default.
• W2034577350 type Work @default.
• W2034577350 sameAs 2034577350 @default.
• W2034577350 citedByCount "94" @default.
• W2034577350 countsByYear W20345773502012 @default.
• W2034577350 countsByYear W20345773502014 @default.
• W2034577350 countsByYear W20345773502015 @default.
• W2034577350 countsByYear W20345773502017 @default.
• W2034577350 countsByYear W20345773502019 @default.
• W2034577350 countsByYear W20345773502020 @default.
• W2034577350 countsByYear W20345773502021 @default.
• W2034577350 countsByYear W20345773502022 @default.
• W2034577350 crossrefType "journal-article" @default.
• W2034577350 hasAuthorship W2034577350A5013650225 @default.
• W2034577350 hasAuthorship W2034577350A5023259092 @default.
• W2034577350 hasAuthorship W2034577350A5039965133 @default.
• W2034577350 hasAuthorship W2034577350A5053691497 @default.
• W2034577350 hasAuthorship W2034577350A5054359089 @default.
• W2034577350 hasAuthorship W2034577350A5074778721 @default.
• W2034577350 hasAuthorship W2034577350A5089768127 @default.
• W2034577350 hasBestOaLocation W20345773501 @default.
• W2034577350 hasConcept C126322002 @default.
• W2034577350 hasConcept C134018914 @default.
• W2034577350 hasConcept C142724271 @default.
• W2034577350 hasConcept C204787440 @default.
• W2034577350 hasConcept C27081682 @default.
• W2034577350 hasConcept C2776312127 @default.
• W2034577350 hasConcept C2777180221 @default.
• W2034577350 hasConcept C2778163477 @default.
• W2034577350 hasConcept C2778270857 @default.
• W2034577350 hasConcept C2778384471 @default.
• W2034577350 hasConcept C2779306644 @default.
• W2034577350 hasConcept C2780473172 @default.
• W2034577350 hasConcept C2991744798 @default.
• W2034577350 hasConcept C555293320 @default.
• W2034577350 hasConcept C71924100 @default.
• W2034577350 hasConceptScore W2034577350C126322002 @default.
• W2034577350 hasConceptScore W2034577350C134018914 @default.
• W2034577350 hasConceptScore W2034577350C142724271 @default.
• W2034577350 hasConceptScore W2034577350C204787440 @default.
• W2034577350 hasConceptScore W2034577350C27081682 @default.
• W2034577350 hasConceptScore W2034577350C2776312127 @default.
• W2034577350 hasConceptScore W2034577350C2777180221 @default.
• W2034577350 hasConceptScore W2034577350C2778163477 @default.
• W2034577350 hasConceptScore W2034577350C2778270857 @default.
• W2034577350 hasConceptScore W2034577350C2778384471 @default.
• W2034577350 hasConceptScore W2034577350C2779306644 @default.
• W2034577350 hasConceptScore W2034577350C2780473172 @default.
• W2034577350 hasConceptScore W2034577350C2991744798 @default.
• W2034577350 hasConceptScore W2034577350C555293320 @default.
• W2034577350 hasConceptScore W2034577350C71924100 @default.
• W2034577350 hasIssue "6" @default.
• W2034577350 hasLocation W20345773501 @default.
• W2034577350 hasLocation W20345773502 @default.
• W2034577350 hasOpenAccess W2034577350 @default.
• W2034577350 hasPrimaryLocation W20345773501 @default.
• W2034577350 hasRelatedWork W1986410768 @default.
• W2034577350 hasRelatedWork W2003150205 @default.
• W2034577350 hasRelatedWork W2033522292 @default.
• W2034577350 hasRelatedWork W2034577350 @default.
• W2034577350 hasRelatedWork W2042938358 @default.
• W2034577350 hasRelatedWork W2053158453 @default.

• next